EICHOR
● Completed
Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)
Condition: Postural Orthostatic Tachycardia Syndrome (POTS) · Sponsor: Regeneron Pharmaceuticals
About this study
This study is researching an experimental drug called REGN7544 (called "study drug"). The study is focused on participants with POTS. The aim of the study is to see how safe, tolerable, and effective the study drug is. The study is looking at several other research questions, including: * How the study drug changes heart rate and blood pressure in participants with POTS * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects) * How the study drug affects symptoms associated with POTS
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (16)
| Mercy Gilbert Medical Center | Gilbert, Arizona, United States | — |
| North County Neurology Associates | Carlsbad, California, United States | — |
| Stanford University | Palo Alto, California, United States | — |
| Southern California Heart Specialists | Pasadena, California, United States | — |
| Yale University | New Haven, Connecticut, United States | — |
| Innovative Research of West Florida, Inc. | Clearwater, Florida, United States | — |
| Indiana University Health Neuroscience Center | Indianapolis, Indiana, United States | — |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | — |
| Mayo Clinic | Rochester, Minnesota, United States | — |
| Saint Luke's MidAmerica Heart Institute | Kansas City, Missouri, United States | — |
| New York University Langone | New York, New York, United States | — |
| University of Oklahoma Health Sciences Center | Oklahoma City, Oklahoma, United States | — |
+ 4 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06593600